Form 4 Tracker
Editas Medicine, Inc.
EDIT

17 insider filings · Latest: Aug 6, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Sep 3, 2024Aug 29 8:17 PMMei Baisong
Proposed Sale
1,000$3.92$3.9K

View →

← Previous

Page 2 of 2

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Aug 6, 2026Aug 7 9:16 PMPatrick Thomas Ellinor IIDirector
Grant/Award
103,400$2.90103,400(D)

View →

Jun 17, 2026Jun 22 8:31 PMBernadette ConnaughtonDirector
Grant/Award
51,700$2.5551,700(D)

View →

Jun 17, 2026Jun 22 8:30 PMJessica HopfieldDirector
Grant/Award
51,700$2.5551,700(D)

View →

Jun 17, 2026Jun 22 8:30 PMAndrew HirschDirector
Grant/Award
51,700$2.5551,700(D)

View →

Jun 17, 2026Jun 22 8:29 PMDavid ScaddenDirector
Grant/Award
51,700$2.5551,700(D)

View →

Jun 17, 2026Jun 22 8:28 PMElliott M. LevyDirector
Grant/Award
51,700$2.5551,700(D)

View →

Mar 12, 2026Mar 16 8:37 PMGilmore Neil O'NeillDirector, CEO
Grant/Award
1,015,200$2.541,015,200(D)

View →

Mar 12, 2026Mar 16 8:35 PMAmy ParisonSVP, Chief Financial Officer
Grant/Award
292,856$2.54292,856(D)

View →

Mar 12, 2026Mar 16 8:34 PMLinda BurklyEVP, CHIEF SCIENTIFIC OFFICER
Grant/Award
292,856$2.54292,856(D)

View →